DCL: BOD approves the transaction contract with related companies
The Board resolution dated April 25, 2019, Cuu Long Pharmaceutical Joint Stock Corporation approved the transaction contract with the following companies:
No.
Content
Relationship
1
F.I.T Group
Parent company
2
VPC – SG Pharma
Subsidiary
3
Euvipharm Pharmaceutical JSC
4
Benovas Cancer Drugs Joint Stock Company
5
Benovas Pharmaceutical JSC
6
Khanh Hoa Mineral Water JSC
Related to member of BOD
7
FIT Consumer JSC
8
Dai Nam Securities Joint Stock Company
9
Safoco
HOSE
> VHC: Change of authorized spokeswoman (26/04/2019)
> HSG: Report on Outstanding Voting Shares (26/04/2019)
> ART: Change in address of the company (26/04/2019)
> Viglacera (VGC) sees profit rise 51 per cent (26/04/2019)
> Masan (MSN) reveals plans to enter home personal care, retail sectors (25/04/2019)
> LMH: Notification Insider Transaction (26/04/2019)
> SMC: Notification Insider Transaction (26/04/2019)
> FUESSV50: NAV 24 Apr 2019 (26/04/2019)
> FUESSV50: Basket of component securities 25 Apr 2019 (26/04/2019)
> E1VFVN30: Announcement after exchange trading 24 Apr 2019 (26/04/2019)
